To lower A1C and regulate your blood sugar, it's important to lose weight, exercise, limit carbs, and use medication like ...

Eli Lilly LLY announced positive top-line data from two late-stage studies evaluating orforglipron, its once-daily oral GLP-1 ...

The ACHIEVE-5 trial (ClinicalTrials.gov identifier: NCT06109311) was a randomized, double-blind, placebo-controlled study that included 546 T2D patients with inadequate glycemic control on insulin ...

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking ...

The company has announced positive data from the ACHIEVE-2 and ACHIEVE-5 trials, with both meeting all their primary and key ...

Time-in-range (TIR) readings from a continuous glucose monitor (CGM) complemented A1c readings and provided a more complete picture of glucose control in patients with type 2 diabetes taking basal ...

Eli Lilly's experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage trials, the company said on Wednesday, as it seeks to widen its lead in the ...

A reduction in glycated hemoglobin (A1C) may result in improved perinatal and maternal outcomes among women with prepregnancy diabetes, according to results of a cohort study published in JAMA Network ...

Dear Dr. Roach: I am a 71-year-old male with Type 2 diabetes. My last A1C test showed a value of 7.8%. I have been taking Mounjaro weekly, which lowered my weight by about 20 pounds and my A1C level ...

Hypothyroidism during pregnancy may have a negative metabolic impact in women with gestational diabetes, with high TSH levels ...